Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
Author:
Funder
Bristol-Myers Squibb
National Institutes of Health
Publisher
Frontiers Media SA
Subject
Immunology,Immunology and Allergy
Reference87 articles.
1. Multiple myeloma;Palumbo;N Engl J Med.,2011
2. Rapidly changing myeloma epidemiology in the general population: increased incidence, older patients, and longer survival;Turesson;Eur J Haematol,2018
3. Combination immune therapies to enhance anti-tumor responses by NK cells;Mentlik;Front Immunol.,2013
4. Proteasome inhibitor-based therapy for treatment of newly diagnosed multiple myeloma;Vandross;Semin Oncol.,2017
5. Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond;Chim;Leukemia,2018
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022;Pharmaceuticals;2024-06-21
2. Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study;Annals of Hematology;2024-03-16
3. PIM2 Kinase Regulates TIGIT Expression and Function in NK Cells from Multiple Myeloma Patients;2024-02-16
4. Natural killer cells affect the natural course, drug resistance, and prognosis of multiple myeloma;Frontiers in Cell and Developmental Biology;2024-02-12
5. Natural Killer Cells: A Promising Cellular Therapy Platform to Conquer Cancer;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3